Accretive Health, Inc. (OTC Pink: ACHI) today announced that it has appointed David Mason as chief strategy officer, effective today.

“Dave brings both significant strategic and operational expertise in the healthcare industry to this position, as well as a proven track record of innovation,” said Emad Rizk, M.D., president and CEO, Accretive Health. “I know of no one better qualified than Dave to help Accretive Health successfully leverage our expertise, expand our capabilities and solidify our position as a proven industry leader.”

Mason brings more than 30 years of healthcare management and hospital revenue cycle experience to Accretive Health, most recently as senior vice president and general manager at RelayHealth, which he joined in 2007. While there, Mason led the company’s Financial Solutions division, where he was responsible for all business operations, business development, strategic planning, product management, client relationships and payer services.

Prior to that, Mason was president of Per-Se Technologies’ Hospital Solutions division, and CEO and executive director of Quantum Radiology. He also held practice management and administration positions at Georgetown University Hospital in Washington, D.C., and Northside Hospital in Atlanta, Ga. He holds a Bachelor of Science degree in Healthcare Administration from Southern Illinois University.

“As Accretive Health’s chief strategy officer, I look forward to working with the leadership team and our talented sales and operations organizations to enhance our comprehensive suite of products and services to help our customers more effectively manage their financial performance,” Mason said. “At the same time, we will have to provide them with the platform and support they need to develop the capabilities required to successfully navigate complex changes occurring in the healthcare industry today and in the future.”

About Accretive Health

At Accretive Health, our mission is to partner with healthcare communities to serve as a catalyst for a healthier future for all. For more information, visit www.accretivehealth.com.

Safe Harbor

This press release contains forward-looking statements, including statements regarding Accretive Health’s future business and growth prospects, and its ability to enhance its product and service offerings. All forward-looking statements contained in this press release involve risks and uncertainties. The company’s actual results and outcomes could differ materially from those anticipated in these forward-looking statements as a result of various factors, including the possibility that the ongoing restatement could have unanticipated consequences and the factors set forth in the company’s quarterly report on Form 10-Q for the quarter ended September 30, 2012, filed with the SEC on November 8, 2012, under the heading “Risk Factors.” The words “strive,” “objective,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “vision,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The company has based these forward-looking statements on its current expectations and projections about future events. Although the company believes that the expectations underlying any of its forward-looking statements are reasonable, these expectations may prove to be incorrect and all of these statements are subject to risks and uncertainties. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected.

All forward-looking statements included in this press release are expressly qualified in their entirety by these cautionary statements. The company cautions readers not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognize that forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the uncertainties and factors described above, as well as others that the company may consider immaterial or does not anticipate at this time. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, the company does not know whether its expectations may prove correct. The company’s expectations reflected in its forward-looking statements can be affected by inaccurate assumptions it might make or by known or unknown uncertainties and factors, including those described above. The risks and uncertainties described above are not exclusive, and further information concerning the company and its business, including factors that potentially could materially affect its financial results or condition or relationships with customers and potential customers, may emerge from time to time. The company assumes no, and it specifically disclaims any, obligation to update, amend, or clarify forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. The company advises investors, however, to consult any further disclosures it makes on related subjects in our periodic reports that it files with or furnishes to the SEC.

Accretive Health, Inc.Investor Relations:Atif Rahim312-324-5476investorrelations@accretivehealth.comorMedia Relations:Brian Pitts312-475-5921brian.pitts@hkstrategies.com

R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more R1 RCM Charts.
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more R1 RCM Charts.